鎮痛薬の市場規模、シェア、動向、予測：タイプ別、薬剤クラス別、投与経路別、疼痛タイプ別、用途別、地域別、2025年～2033年

鎮痛薬の市場の世界市場規模は、2024年に563億2,000万米ドルとなった。今後、IMARC Groupは、2033年には810億6,000万米ドルに達し、2025～2033年のCAGRは3.71%になると予測しています。現在、北米が市場を独占しており、2024年には32.8％を超える大きな市場シェアを占めています。同市場は主に、慢性疼痛疾患の有病率の上昇、世界の高齢者人口の増加、薬剤製剤の大幅な技術進歩によって牽引されています。また、非オピオイド鎮痛薬や一般用医薬品（OTC）に対する需要も高まっており、市場の見通しは明るいです。

鎮痛剤は、主に痛みや不快感を緩和するために開発された物質や薬剤です。根本的な原因に対処することなく、神経系を標的として痛みの知覚を抑えることで効果を発揮します。非ステロイド性抗炎症薬（NSAIDs）、オピオイド、非オピオイドに分類されます。さらに、イブプロフェンやアスピリンなどのNSAIDsは、炎症を緩和することで痛みを軽減します。モルヒネやコデインなどのオピオイドは、中枢神経系に作用し、より強力な鎮痛効果をもたらすが、これには中毒性があります。その結果、アセトアミノフェンを含む非オピオイド鎮痛薬の人気が高まっており、オピオイドの中毒性リスクを伴わずに鎮痛効果を発揮します。

市場を牽引しているのは、疼痛関連疾患の増加と疼痛管理の重要性に対する意識の高まりです。さらに、がん、糖尿病、心血管疾患などの慢性疾患の蔓延は、しばしば慢性疼痛を症状として伴うため、鎮痛剤の使用による緩和が必要となり、市場成長に影響を与えています。さらに、医療技術の進歩により、外科手術や術後の疼痛管理が増加し、病院や診療所での鎮痛剤の使用につながっており、これも成長を促す大きな要因となっています。これに加えて、老年人口が増加しているため、関節炎や筋骨格系障害などの慢性疼痛状態に陥りやすく、これが製品需要を加速させています。これに加え、座りっぱなしのライフスタイル、姿勢の悪さ、ストレスレベルの増加が痛みの訴えを増加させる一因となっており、その結果、頭痛、腰痛、筋肉痛の緩和のために市販薬を求める人が増え、市場の成長を促進しています。

鎮痛薬の市場傾向／促進要因：

慢性疾患の増加

関節炎や片頭痛などの慢性疾患の流行が市場を牽引しています。加えて、老年人口が増加しているため、関節炎、変形性関節症、関節リウマチなどの慢性的な健康状態にかかりやすくなっており、これらは持続的な関節痛や炎症を特徴とすることが多く、疼痛管理のために鎮痛薬を使用する必要があるため、市場の成長に影響を与えています。さらに、糖尿病、心血管障害、がんなどの慢性疾患の罹患率が上昇していることも、疼痛緩和ソリューションの需要を高めており、もう一つの大きな成長促進要因となっています。これらの疾患の多くは疼痛症状や治療による副作用を伴うため、鎮痛薬は疼痛管理や緩和ケア戦略に不可欠な要素となっています。さらに、ライフスタイルの変化が慢性疾患の急増に寄与しており、座りっぱなしのライフスタイル、食生活の乱れ、慢性腰痛、片頭痛、線維筋痛症などに関連する高ストレスレベルが、不快感を和らげ、生活の質を高めるために鎮痛薬を採用する結果となり、市場の前向きな見通しを生み出しています。

新規鎮痛薬とドラッグデリバリーの開発

市場は最近の動向、特に新規薬剤と革新的なデリバリー方法の開発において著しい進歩を遂げています。こうした進歩は、状況を再構築する上で不可欠です。また、製薬企業は研究開発（R&D）に投資し、副作用を最小限に抑えながらより効果的に鎮痛効果を発揮する新薬を開発しており、市場の成長に影響を与えています。これらの医薬品は、しばしば体内の特定の疼痛経路を標的とするため、疼痛管理により適したアプローチを提供します。さらに、遺伝学と薬理ゲノミクスの進歩により、個別化された疼痛管理が可能になり、医療提供者が医薬品を処方する際に患者の遺伝的体質を考慮することで、よりオーダーメイドで効果的な治療アプローチが確保されるようになったことも、成長を促す大きな要因となっています。これとともに、経皮パッチ、静脈内注入、皮下注射など、いくつかの革新的な送達方法は、鎮痛薬の投与に代わる方法を提供し、制御された持続的な鎮痛をもたらし、患者のコンプライアンスを向上させることができるため、市場の成長を後押ししています。

市販薬（OTC）に対する需要の高まり

市場の拡大は、一般用医薬品（OTC）セグメントの拡大によるものです。加えて、消費者は健康管理に積極的になり、頭痛、筋肉痛、軽い怪我などの一般的な病気に対処する際に利便性とアクセスのしやすさを求めるようになっており、市場成長に影響を与えています。さらに、薬局や小売店の増加により、OTC鎮痛薬の取り扱いが拡大し、さまざまな痛み緩和ニーズに対応する複数のブランドや製剤を含むこれらの製品が消費者にとってより利用しやすくなっていることも、成長を促す大きな要因となっています。これに加えて、OTC医薬品の安全性、有効性、適切な使用方法、潜在的な副作用に対する意識の高まりが、これらの製品に対する信頼を築き、市場の成長を加速させています。これに加え、現代のライフスタイルは多忙なスケジュールやストレスを伴うため、頭痛や体の痛みが増加し、その結果、OTC鎮痛剤が採用されるようになり、購入や使用が容易なことから、こうした日常の不快感から素早く解放されたいと考える個人にとって最適な選択肢となっています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の鎮痛薬市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場内訳：タイプ別
• 市場内訳：薬剤クラス別
• 市場内訳：投与経路別
• 市場内訳：疼痛タイプ別
• 市場内訳：用途別
• 市場内訳：地域別
• 市場予測

第6章 市場内訳：タイプ別

• 処方箋
  • 市場動向
  • 市場予測
• 市販薬（OTC）
  • 市場動向
  • 市場予測

第7章 市場内訳：薬剤クラス別

• オピオイド
  • 市場動向
  • 市場予測
• NSAID
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第8章 市場内訳：投与経路別

• 経口
  • 市場動向
  • 市場予測
• 非経口
  • 市場動向
  • 市場予測
• 外用
  • 市場動向
  • 市場予測
• 経皮
  • 市場動向
  • 市場予測
• 直腸
  • 市場動向
  • 市場予測

第9章 市場内訳：疼痛タイプ別

• 筋骨格
  • 市場動向
  • 市場予測
• 外科・外傷
  • 市場動向
  • 市場予測
• がん
  • 市場動向
  • 市場予測
• 神経障害
  • 市場動向
  • 市場予測
• 片頭痛
  • 市場動向
  • 市場予測
• 産科
  • 市場動向
  • 市場予測
• 線維筋痛症
  • 市場動向
  • 市場予測
• 火傷による痛み
  • 市場動向
  • 市場予測
• 歯科・フェイシャル
  • 市場動向
  • 市場予測
• 小児科
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第10章 市場内訳：用途別

• 内部
  • 市場動向
  • 市場予測
• 外部
  • 市場動向
  • 市場予測

第11章 市場内訳：地域別

• アジア太平洋地域
• 北米
• 欧州
• 中東・アフリカ
• ラテンアメリカ

第12章 世界の鎮痛薬産業：SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第13章 世界の鎮痛薬産業：バリューチェーン分析

• 概要
• 研究開発
• 原材料調達
• 製造
• マーケティング
• 流通
• 最終用途

第14章 世界の鎮痛薬産業：ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第15章 世界の鎮痛薬産業：価格分析

• 価格指標
• 価格構造
• マージン分析

第16章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Bayer AG
  • Novartis International AG
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Johnson & Johnson Pvt. Ltd.
  • Reckitt Benckiser（RB）Group PLC
  • Endo Pharmaceuticals PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Sanofi SA

List of Figures

• Figure 1: Global: Analgesics Market: Major Drivers and Challenges
• Figure 2: Global: Analgesics Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Analgesics Market: Breakup by Type (in %), 2024
• Figure 4: Global: Analgesics Market: Breakup by Drug Class (in %), 2024
• Figure 5: Global: Analgesics Market: Breakup by Route of Administration (in %), 2024
• Figure 6: Global: Analgesics Market: Breakup by Pain Type (in %), 2024
• Figure 7: Global: Analgesics Market: Breakup by Application (in %), 2024
• Figure 8: Global: Analgesics Market: Breakup by Region (in %), 2024
• Figure 9: Global: Analgesics Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 10: Global: Analgesics Industry: SWOT Analysis
• Figure 11: Global: Analgesics Industry: Value Chain Analysis
• Figure 12: Global: Analgesics Industry: Porter's Five Forces Analysis
• Figure 13: Global: Analgesics (Prescription) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Analgesics (Prescription) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Analgesics (Over the counter-OTC) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Analgesics (Over the counter-OTC) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Analgesics (Opioids) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Analgesics (Opioids) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Analgesics (NSAID) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Analgesics (NSAID) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Analgesics (Others) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Analgesics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Analgesics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Analgesics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Analgesics (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Global: Analgesics (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Global: Analgesics (Topical) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Global: Analgesics (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Global: Analgesics (Transdermal) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Global: Analgesics (Transdermal) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Global: Analgesics (Rectal) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Global: Analgesics (Rectal) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Global: Analgesics (Musculoskeletal) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Global: Analgesics (Musculoskeletal) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Global: Analgesics (Surgical and Trauma) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Global: Analgesics (Surgical and Trauma) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Global: Analgesics (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Global: Analgesics (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Global: Analgesics (Neuropathic) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Global: Analgesics (Neuropathic) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Global: Analgesics (Migraine) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Global: Analgesics (Migraine) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Global: Analgesics (Obstetrical) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Global: Analgesics (Obstetrical) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: Global: Analgesics (Fibromyalgia) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: Global: Analgesics (Fibromyalgia) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Global: Analgesics (Pain due to Burns) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Global: Analgesics (Pain due to Burns) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: Global: Analgesics (Dental/Facial) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: Global: Analgesics (Dental/Facial) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Global: Analgesics (Pediatric) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Global: Analgesics (Pediatric) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Global: Analgesics (Other Pain Types) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Global: Analgesics (Other Pain Types) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Global: Analgesics (Internal) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Global: Analgesics (Internal) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Global: Analgesics (External) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Global: Analgesics (External) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: North America: Analgesics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: North America: Analgesics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Europe: Analgesics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Europe: Analgesics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: Asia Pacific: Analgesics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: Asia Pacific: Analgesics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: Middle East and Africa: Analgesics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: Middle East and Africa: Analgesics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: Latin America: Analgesics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: Latin America: Analgesics Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

• Table 1: Global: Analgesics Market: Key Industry Highlights, 2024 & 2033
• Table 2: Global: Analgesics Market Forecast: Breakup by Type (in Million USD), 2025-2033
• Table 3: Global: Analgesics Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
• Table 4: Global: Analgesics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
• Table 5: Global: Analgesics Market Forecast: Breakup by Pain Type (in Million USD), 2025-2033
• Table 6: Global: Analgesics Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 7: Global: Analgesics Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 8: Global: Analgesics Market Structure
• Table 9: Global: Analgesics Market: Key Players

The global analgesics market size was valued at USD 56.32 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 81.06 Billion by 2033, exhibiting a CAGR of 3.71% during 2025-2033. North America currently dominates the market, holding a significant market share of over 32.8% in 2024. The market is mainly driven by the rising prevalence of chronic pain conditions, an increasing global geriatric population, and significant technological advancements in drug formulations. There is also a growing demand for non-opioid and over-the-counter (OTC) pain relievers which creates a positive outlook for the market.

Analgesics are substances or medications primarily developed to alleviate pain and discomfort. It works by targeting the nervous system to reduce the perception of pain without addressing the underlying cause. It can be classified into non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and non-opioids. Additionally, NSAIDs, including ibuprofen and aspirin, reduce pain by mitigating inflammation. Opioids, such as morphine and codeine, act on the central nervous system to provide more potent pain relief, which can have addictive potential. As a result, the growing popularity of non-opioid analgesics, including acetaminophen, offers pain relief without the addictive risks of opioids.

The market is driven by increasing incidences of pain-related conditions and a growing awareness of the importance of pain management. In addition, the prevalence of chronic ailments, including cancer, diabetes, and cardiovascular diseases, often come with chronic pain as a symptom, requiring the use of analgesics for relief, thus influencing market growth. Moreover, advances in medical technology led to more surgical interventions and post-operative pain management, leading to the use of analgesics in hospitals and clinics, representing another major growth-inducing factor. Besides this, the growing geriatric population is prone to chronic pain conditions such as arthritis and musculoskeletal disorders, which is accelerating the product demand. Along with this, sedentary lifestyles, poor posture, and increased stress levels contribute to increasing pain complaints, resulting in individuals seeking over-the-counter medicines for relief from headaches, back pain, and muscle aches, propelling the market growth.

Analgesics Market Trends/Drivers:

The growing incidences of chronic ailments

The market is driven by the prevalence of chronic ailments such as arthritis, and migraines. In addition, the growing geriatric population is more susceptible to chronic health conditions such as arthritis, osteoarthritis, and rheumatoid arthritis which are often characterized by persistent joint pain and inflammation, requiring the use of analgesics for pain management, is influencing the market growth. Moreover, the rising incidence of chronic diseases including diabetes, cardiovascular disorders, and cancer are escalating the demand for pain relief solutions, representing another major growth-inducing factor. Many of these diseases are associated with painful symptoms or side effects of treatments, making analgesics an essential component of the management and palliative care strategies. Furthermore, lifestyle changes are contributing to the surge in chronic ailments, sedentary lifestyles, poor dietary habits, and high-stress levels linked to conditions such as chronic back pain, migraines, and fibromyalgia, resulting in the adoption of analgesics to alleviate their discomfort and enhance their quality of life, are creating a positive market outlook.

The development of novel analgesic drugs and delivery methods

The market has witnessed significant advancements in recent years, particularly in the development of novel drugs and innovative delivery methods. These advancements are essential in reshaping the landscape. In addition, pharmaceutical companies are investing in research and development (R&D) to create novel drugs developed to be more effective in providing pain relief while minimizing side effects, influencing market growth. They often target specific pain pathways in the body, offering a more tailored approach to pain management. Moreover, advances in genetics and pharmacogenomics allowed for personalized pain management., and healthcare providers consider a patient's genetic makeup when prescribing medicines, ensuring a more tailored and effective treatment approach, representing another major growth-inducing factor. Along with this, several innovative delivery methods, including transdermal patches, intravenous infusions, and subcutaneous injections offer alternative ways to administer analgesics that can provide controlled, sustained pain relief and improve patient compliance, propelling the market growth.

Escalating demand for over-the-counter (OTC) medicines

The market expansion is due to growing the over-the-counter (OTC) segment. In addition, consumers are becoming more proactive in managing their health and seek convenience and accessibility when it comes to addressing common ailments including headaches, muscle pain, or minor injuries, thus influencing the market growth. Moreover, the growing pharmacies and retail outlets are expanding their OTC analgesic offerings, making these products more accessible to consumers including several brands and formulations, catering to different pain relief needs, representing another major growth-inducing factor. Besides this, the growing awareness of OTC drugs' safety, effectiveness, proper use, and potential side effects, has built trust in these products, thus accelerating the market growth. Along with this, modern lifestyles involve hectic schedules and stress, leading to increased instances of headaches and body aches resulting in the adoption of OTC analgesics, with their ease of purchase and use becoming a go-to choice for individuals seeking quick relief from these everyday discomforts.

Analgesics Industry Segmentation:

Breakup by Type:

• Prescription
• Over the counter (OTC)

Prescription analgesics represent the most popular type

The prescription analgesics market is typically dispensed under the supervision of a healthcare professional. It offers a higher level of efficacy and potency compared to its over-the-counter (OTC) counterparts which are often recommended for patients experiencing severe or chronic pain. This effectiveness makes them a preferred choice for healthcare providers when managing pain associated with conditions including post-surgical recovery, cancer, and advanced musculoskeletal disorders.

Moreover, it includes numerous drug classes, allowing healthcare practitioners to tailor treatment to the specific needs of individual patients, thus representing another major growth-inducing factor. It includes opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and adjuvant medications, each addressing different types and levels of pain.

Besides this, the rising importance of proper dosage and monitoring by healthcare professionals to minimize the risk of misuse, addiction, and adverse side effects, particularly concerning opioids is accelerating the market growth.

Additionally, the growing geriatric population is contributing to the escalating demand for prescription analgesics to experience chronic pain conditions, requiring specialized pain management that often involves prescription medications is propelling the market growth.

Breakup by Drug Class:

• Opioids
• NSAID
• Others

Opioids hold the largest share of the market

Opioids are a class of potent pain-relieving medications that act on the body's opioid receptors, providing effective relief from moderate to severe pain. In addition, opioids are employed to manage pain and are effective for severe pain, such as that experienced post-surgery, during cancer treatment, or in cases of chronic pain conditions, influencing the market growth. This effectiveness has made opioids a preferred choice for healthcare professionals and patients seeking relief from intense pain.

Moreover, opioids are used in pain management, with some formulations dating back centuries. While concerns about addiction and misuse exist, proper medical supervision and stringent prescription regulations helped curb these risks.

Additionally, the development of extended-release formulations that provide prolonged pain relief expanded the range of conditions for which opioids can be prescribed safely and effectively, thus augmenting the market growth.

Furthermore, the prevalence of chronic pain conditions, such as osteoarthritis and lower back pain is escalating the demand for opioids due to the growing geriatric population and as the burden of chronic pain, which is propelling the market growth.

Breakup by Route of Administration:

• Oral
• Parenteral
• Topical
• Transdermal
• Rectal

Oral presently accounts for the largest market share

The oral route of administration established itself as the dominant choice in the global market. In addition, the increasing use of oral analgesics offers convenience and ease of use that are available in various forms, including tablets, capsules, and liquids, making them accessible to numerous patients, and influencing the market growth. This versatility in dosage forms allows healthcare providers to tailor pain relief regimens to individual patient needs, enhancing patient compliance.

Moreover, oral medications are familiar among healthcare professionals and patients employed for numerous health conditions which fosters trust and confidence in the effectiveness of these medications, representing another major growth-inducing factor.

Besides this, the oral route provides a reliable and consistent absorption profile with a predictable absorption pattern, and ensures consistent pain relief for patients, accelerating the market growth.

Furthermore, the wide range of oral medications available, from over-the-counter (OTC) products to prescription medications, cater to various pain management needs are propelling the market growth.

Breakup by Pain Type:

• Musculoskeletal
• Surgical and Trauma
• Cancer
• Neuropathic
• Migraine
• Obstetrical
• Fibromyalgia
• Pain due to Burns
• Dental/Facial
• Pediatric
• Others

Musculoskeletal pain dominates the market

Musculoskeletal pain includes numerous conditions affecting the muscles, bones, tendons, ligaments, and joints. It includes ailments such as osteoarthritis, rheumatoid arthritis, back pain, and sports-related injuries, among others.

Besides this, the growing geriatric population is susceptible to musculoskeletal pain due to the natural degeneration of joints and tissues. This shift led to a substantial increase in the prevalence of conditions including osteoarthritis, which often requires pain management solutions.

Apart from this, sedentary lifestyles, lack of physical activity, and poor ergonomics in work environments contribute to musculoskeletal issues. Individuals working long hours at desks or engaging in repetitive tasks are more susceptible to conditions including chronic back pain and carpal tunnel syndrome, driving the demand for medications.

Breakup by Application:

• Internal
• External

Internal application of analgesics involves the ingestion or injection of pain-relief medications which includes oral tablets, capsules, liquids, and injectable forms. It is developed to provide systemic relief by acting on the central nervous system, making it suitable for various pain types, including headaches, post-surgical pain, and systemic conditions.

External application of analgesics involves the use of topical formulations, such as creams, gels, patches, and ointments, applied directly to the skin at the site of pain. These products are designed to provide localized relief, making them particularly effective for musculoskeletal pain, joint pain, and surface injuries. It is gaining traction in the market due to its non-invasive nature, reduced risk of systemic side effects, and ease of use. Additionally, they are preferred by individuals seeking targeted pain relief without affecting the entire body.

Breakup by Region:

• Asia Pacific
• North America
• Europe
• Middle East and Africa
• Latin America

North America leads the market, accounting for the majority of the analgesics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North America market is driven by the growing healthcare infrastructure and rising healthcare expenditure. The United States boasts advanced medical facilities, a well-established pharmaceutical industry, and a strong emphasis on pain management to create a conducive environment for the development, manufacturing, and distribution of analgesic products.

Additionally, the prevalence of chronic pain conditions in the region is augmenting the market growth. Also, chronic pain affects millions of individuals across North America, with ailments including chronic lower back pain, osteoarthritis, and neuropathic pain being common which requires a consistent demand for medications and treatments, thus propelling the market growth.

Furthermore, the proactive approach to pain management and the promotion of pain relief options contribute to market domination. Healthcare professionals in the region are actively advocating for patient access to pain relief, and this awareness is further escalating the demand for medications.

Competitive Landscape:

At present, key players in the market are implementing various strategies to strengthen their positions and stay competitive in this dynamic industry. These strategies are driven by the need to address evolving consumer preferences, regulatory changes, and market trends. They are allocating substantial resources to research and develop (R&D) new drugs and formulations that offer improved pain relief, reduce side effects, and enhance patient compliance. It also focuses on exploring non-opioid alternatives to address concerns about opioid addiction and misuse. Moreover, companies are expanding their product portfolios by acquiring or partnering with smaller firms specializing in complementary pain management solutions which allows them to offer a wider range of medications, including over-the-counter (OTC) and prescription medications, topical creams, and medical devices. Besides this, key players are helping companies establish a strong presence in the market by collaborating with healthcare professionals to educate patients and providers about the benefits of their products.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Bayer AG
• Novartis International AG
• GlaxoSmithKline PLC
• Pfizer Inc.
• Johnson & Johnson Pvt. Ltd.
• Reckitt Benckiser (RB) Group PLC
• Endo Pharmaceuticals PLC
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Sanofi SA

Key Questions Answered in This Report

• 1.How big is the analgesics market?
• 2.What is the future outlook of analgesics market?
• 3.What are the key factors driving the analgesics market?
• 4.Which region accounts for the largest analgesics market share?
• 5.Which are the leading companies in the global analgesics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Analgesics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Type
• 5.5 Market Breakup by Drug Class
• 5.6 Market Breakup by Route of Administration
• 5.7 Market Breakup by Pain Type
• 5.8 Market Breakup by Application
• 5.9 Market Breakup by Region
• 5.10 Market Forecast

6 Market Breakup by Type

• 6.1 Prescription
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Over the counter (OTC)
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Drug Class

• 7.1 Opioids
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 NSAID
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Route of Administration

• 8.1 Oral
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Parenteral
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Topical
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Transdermal
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Rectal
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Pain Type

• 9.1 Musculoskeletal
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Surgical and Trauma
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Cancer
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Neuropathic
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Migraine
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast
• 9.6 Obstetrical
  • 9.6.1 Market Trends
  • 9.6.2 Market Forecast
• 9.7 Fibromyalgia
  • 9.7.1 Market Trends
  • 9.7.2 Market Forecast
• 9.8 Pain due to Burns
  • 9.8.1 Market Trends
  • 9.8.2 Market Forecast
• 9.9 Dental/Facial
  • 9.9.1 Market Trends
  • 9.9.2 Market Forecast
• 9.10 Pediatric
  • 9.10.1 Market Trends
  • 9.10.2 Market Forecast
• 9.11 Others
  • 9.11.1 Market Trends
  • 9.11.2 Market Forecast

10 Market Breakup by Application

• 10.1 Internal
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 External
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 Market Trends
  • 11.1.2 Market Forecast
• 11.2 Europe
  • 11.2.1 Market Trends
  • 11.2.2 Market Forecast
• 11.3 Asia Pacific
  • 11.3.1 Market Trends
  • 11.3.2 Market Forecast
• 11.4 Middle East and Africa
  • 11.4.1 Market Trends
  • 11.4.2 Market Forecast
• 11.5 Latin America
  • 11.5.1 Market Trends
  • 11.5.2 Market Forecast

12 Global Analgesics Industry: SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Global Analgesics Industry: Value Chain Analysis

• 13.1 Overview
• 13.2 Research and Development
• 13.3 Raw Material Procurement
• 13.4 Manufacturing
• 13.5 Marketing
• 13.6 Distribution
• 13.7 End-Use

14 Global Analgesics Industry: Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Global Analgesics Industry: Price Analysis

• 15.1 Price Indicators
• 15.2 Price Structure
• 15.3 Margin Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 Bayer AG
  • 16.3.2 Novartis International AG
  • 16.3.3 GlaxoSmithKline PLC
  • 16.3.4 Pfizer Inc.
  • 16.3.5 Johnson & Johnson Pvt. Ltd.
  • 16.3.6 Reckitt Benckiser (RB) Group PLC
  • 16.3.7 Endo Pharmaceuticals PLC
  • 16.3.8 Bristol-Myers Squibb Company
  • 16.3.9 Eli Lilly and Company
  • 16.3.10 Sanofi SA